Loss of the Pro-Apoptotic BH3-only Bcl-2 Family Member Bim Inhibits BCR Stimulation–induced Apoptosis and Deletion of Autoreactive B Cells by Enders, Anselm et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2003/10/1119/8 $8.00
Volume 198, Number 7, October 6, 2003 1119–1126
http://www.jem.org/cgi/doi/10.1084/jem.20030411
 
Brief Deﬁnitive Report
 
1119
 
Loss of the Pro-Apoptotic BH3-only Bcl-2 Family Member 
Bim Inhibits BCR Stimulation–induced Apoptosis and 
Deletion of Autoreactive B Cells
 
Anselm Enders,
 
 
 
Philippe Bouillet, Hamsa Puthalakath, Yuekang Xu, 
 
David M. Tarlinton, and Andreas Strasser
 
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia
 
Abstract
 
During development, the stochastic process assembling the genes encoding antigen receptors
invariably generates B and T lymphocytes that can recognize self-antigens. Several mechanisms
have evolved to prevent the activation of these cells and the concomitant development of
autoimmune disease. One such mechanism is the induction of apoptosis in developing or
mature B cells by engagement of the B cell antigen receptor (BCR) in the absence of T cell
help. Here we report that B lymphocytes lacking the pro-apoptotic Bcl-2 family member Bim
are refractory to apoptosis induced by BCR ligation in vitro. The loss of Bim also inhibited
deletion of autoreactive B cells in vivo in two transgenic systems of B cell tolerance. Bim loss
prevented deletion of autoreactive B cells induced by soluble self-antigen and promoted accu-
mulation of self-reactive B cells developing in the presence of membrane-bound self-antigen,
although their numbers were considerably lower compared with antigen-free mice. Mechanis-
tically, we determined that BCR ligation promoted interaction of Bim with Bcl-2, inhibiting
its survival function. These findings demonstrate that Bim is a critical player in BCR-mediated
apoptosis and in B lymphocyte deletion.
Key words: apoptosis • transgenic mice • tolerance • gene knockout • autoimmunity
 
Introduction
 
The combinatorial nature of the genetic rearrangements
that mediate the formation of the Ig genes ensures diversity
in the B lymphocyte repertoire and the ability to recognize
numerous foreign antigens. However, It also entails the
development of B lymphocytes expressing self-reactive Ig
molecules. Whereas a degree of self-reactivity may be essential
for the development and survival of B lymphocytes (1), inter-
actions of too high an affinity may be deleterious to the
well being of the organism. Thus, several mechanisms have
evolved to ensure that B cells bearing potentially harmful
antiself specificities are removed from the system (2). These
mechanisms, so far defined on the basis of experimental
observation, include the functional silencing of the lympho-
cytes in a process termed anergy (3, 4), the reinduction of
gene rearrangement at the Ig heavy and light chain loci to
generate edited receptors with nonself reactivity (5, 6), and
finally the deletion of autoreactive B cells at specific points
during development (7–9). Although the precise mecha-
nisms ensuring these various forms of negative selection
remain undefined, it is clear that the induction of apoptosis
is critical (10, 11).
Two distinct but convergent apoptosis signaling pathways
activate the aspartate-specific cysteine proteases (caspases)
that mediate cell death (12, 13). Ligation of certain receptors
belonging to the TNF receptor (TNF-R) family, such as
CD95 (Fas/APO-1) or TNF-R1, activates caspase-8 via
the adaptor protein FADD/MORT1. The other pathway
is regulated by the interplay of pro- and anti-apoptotic
members of the Bcl-2 family and is amplified by, but not
fully dependent on, the action of the cytochrome c/Apaf-1–
caspase-9 apoptosome(12–14).
Deletion of activated B cells can be mediated through
interaction with FasL on CD4
 
 
 
 T lymphocytes (15, 16),
which explains why not only T cells but also B cells con-
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tribute to lymphadenopathy in mutant Fas- (
 
lpr
 
) and FasL-
deficient (
 
gld
 
) mice (17). The death receptor pathway is,
however, dispensable for BCR ligation–induced deletion
of immature and mature resting B lymphocytes in vivo (15,
18). Moreover, BCR ligation–induced apoptosis of B lym-
phoma–derived cell lines and primary B cells is indepen-
dent of Fas (19) and not inhibited by blocking the function
of FADD or caspase-8 (19, 20). In contrast, this death can
be prevented by overexpression of Bcl-2 or Bcl-x
 
L 
 
(19), in-
dicating that pro-apoptotic Bcl-2 family members might be
the critical initiators of apoptosis in B lymphocyte–negative
selection. Recent genetic and biochemical studies have
shown that apoptosis is initiated by BH3-only Bcl-2 family
members, which share with their relatives only the short
BH3 interaction domain (21) and that pro-apoptotic Bax
and Bak, which are structurally more akin to the anti-apop-
totic Bcl-2 family members, act downstream in the cell
death program (21). We were prompted to investigate the
role of the BH3-only protein Bim (22) in B lymphocyte–
negative selection when disruption of the 
 
bim
 
 gene showed
it to be a critical regulator of lymphocyte homeostasis, a
barrier against autoimmune disease (23), and necessary for
killing of autoreactive thymocytes (24) and mature, anti-
gen-activated T cells (25, 26).
 
Materials and Methods
 
Mice.
 
The generation and genotyping of 
 
bim
 
 
 
/
 
 
 
 mice (23),
MD4 transgenic mice expressing anti-HEL Ig (specific for hen
egg lysozyme) in their B cells (3), soluble HEL (sHEL) (3) or
membrane-bound HEL (mHEL) (8) in a wide range of cell types,
and 
 
vav
 
–
 
bcl
 
-2 transgenic mice (27), which express human Bcl-2
under the control of the 
 
vav
 
 promoter region in all hemopoietic
cells, have been described. All animals were on a C57BL/6
(N 
 
 
 
 10) background and were analyzed at 5–10 wk of age, ex-
cept some 
 
vav–bcl
 
-2 mice that were analyzed at 6 mo. Some ex-
periments used C57BL/6 mice congenic for Ly5.1, with or with-
out the MD4 Ig transgene. These latter mice were bred and
maintained at the Walter and Eliza Hall Institute. BM reconstitu-
tions were as described (28), and recipients were analyzed at least
8 wk post reconstitution.
 
Anti-IgM Antibody Treatment.
 
Immature and mature B cells
from control (WT), 
 
bim
 
 
 
/
 
 
 
, and 
 
vav
 
–
 
bcl
 
-2 transgenic mice were
purified by positive or negative sorting from spleen and LNs, re-
spectively (see Immunofluorescence Staining, Flow Cytometric
Analysis, and Cell Isolation) and then cultured in the presence of
graded concentrations of F(ab
 
 
 
)
 
2
 
 goat anti–mouse IgM antibodies
(Jackson ImmunoResearch Laboratories), either soluble or plate
bound via biotin-avidin. B cells were harvested 15 h later, and the
proportion of live and apoptotic cells was determined by staining
with FITC-coupled annexin V (PharMingen) and propidium io-
dide (PI) followed by analysis in a FACScan
 
®
 
 (Becton Dickinson).
Specific cell viability after culture with anti-IgM antibodies was
calculated by dividing the cell survival in the stimulated culture
with that from the unstimulated culture and expressing the result
as a percentage. Thus, the unstimulated culture is always 100%
survival and the stimulated culture some fraction of this.
 
Immunofluorescence Staining, Flow Cytometric Analysis, and Cell
Isolation.
 
B lymphocytes were stained in 10% 2.4G2 (anti–
mouse Fc
 
 
 
RII) hybridoma supernatant plus 1% normal rat serum
with mAbs RA3–6B2 (anti–CD45-R/B220), 1D3 (anti-CD19),
331.12 (anti-IgM), 11.2C (anti-IgD), 187.1 (anti-Ig
 
 
 
 light chain),
LS132 (anti-Ig
 
 
 
 light chain), 7G6 (anti-CD21), and AMS9.1
(anti-IgDa) conjugated with Cy5, FITC, R-PE, or biotin. Anti-
bodies were produced and conjugated to fluorochromes in our
laboratory. Immature B cells were collected as the B220
 
lo
 
sIgM
 
 
 
fraction from among BM cells stained with 331.12 (anti-IgM) and
RA3–6B2 (anti-B220). For sorting mature B cells, LN cells were
stained with 30H12 (anti-Thy1), M1/70 (anti-Mac1), RB6–8C5
(anti-Gr1), and Ter119 (anti-erythroid cell marker), all labeled
with FITC, and B cells were collected as the FITC-negative frac-
tion using a high speed cell sorter. Efficiency of the sort was de-
termined by staining an aliquot of the sorted cells with anti-B220
mAb and was found on analysis to always exceed 95%. Biotin-
ylated antibodies and biotinylated HEL were detected with R-PE-
or TRI-COLOR streptavidin (Caltag). Flow cytometric analysis
Figure 1. Bim is required for BCR ligation–induced killing of immature
and mature B lymphocytes. (A) Immature B cells sorted from spleen as
B220 IgM IgD  were cultured overnight in the presence of F(ab )2 anti-
IgM antibodies and then assessed for viability. Cell survival after 15 h
BCR ligation was calculated as a percentage of B cell survival in unstimulated
cultures. B cells show a dose-dependent killing reaching 60% at 50  g/mL
for controls, 30% for bim / , and  10% for bcl-2 transgene-expressing
cells. (B) Same as for A, except mature B cells were negatively sorted
from LNs as Thy1 Mac-1 Gr-1 Ter119  cells. Control B cells show
50% death at 50  g/mL F(ab )2 anti-IgM antibodies, whereas bim /  and
bcl-2 transgenic B cells show 15 and 5%, respectively. (C) Same as for B,
except B cells were stimulated with plate-bound F(ab )2 anti-IgM antibodies,
inducing more severe cell death as evidenced by the 80% cell death of control
B cells, 40% death of bim /  B cells, and 20% death of bcl-2 transgene-
expressing B cells at 50  g/mL anti-IgM antibody concentration.T
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of viable cells (those excluding PI) used a FACScan
 
®
 
 or LSR
(Becton Dickinson), whereas cell sorting used either a MoFlo
(Cytomation) or FACS
 
®
 
 Diva (Becton Dickinson) high speed cell
sorter.
 
Mature B Cell Transfer.
 
Mature B cells were prepared from
pooled spleens and LNs of two Ly5.2 
 
bim
 
 
 
/
 
 
 
 and four Ly5.1
 
bim
 
 
 
/
 
 
 
 Ig transgenic mice. After red cell lysis, T cells were de-
pleted using complement mediated killing of cells labeled with
antibodies specific for Thy1, CD4, and CD8 following estab-
lished protocols. The resulting enriched B cell suspensions (70–
80% B220
 
 
 
 HEL binding) were mixed in a ratio of 2 
 
bim
 
 
 
/
 
 
 
 to 1
 
bim
 
 
 
/
 
 
 
 transgenic B cells and injected i.v. into C57BL/6 recipi-
ents that were either soluble HEL (sHEL)
 
 
 
 or sHEL
 
 
 
 (control)
recipients. At 2 and 5 d post transfer, recipients were killed, had
their spleens removed, and lymphocytes were prepared and ana-
lyzed by flow cytometry for the presence of HEL-binding IgDa
 
 
 
B cells that were either Ly5.1
 
 
 
 or Ly5.2
 
 
 
. Staining with fluores-
cent antibodies and subsequent analysis was as described above.
Uninjected C57BL/6 mice were used to define the level of de-
tection of such B cells.
 
Cell Stimulation, Lysis, Immunoprecipitation, and Western Blot-
ting.
 
B cells purified from spleen using anti-B220 MACS beads
(Miltenyi Biotechnology GmbH) were cultured overnight at a
concentration of 10
 
7
 
/mL with or without 10 
 
 
 
g/mL F(ab
 
 
 
)
 
2
 
goat anti–mouse IgM antibodies. Subsequent lysis was per-
formed as described (29) in a final volume of 200 
 
 
 
L which was
then divided equally in two. Bcl-2 was immunoprecipitated
from each 100
 
  
 
L of extract with a hamster anti–mouse Bcl-2
mAb (clone 3F11) conjugated and cross-linked to protein G
sepharose. Bound proteins were eluted with 200 
 
 
 
L of 0.1 M
glycine-HCl, pH 2.7, then precipitated with 3 vol of chilled ac-
etone and washed with 70% ethanol. The precipitates were each
dissolved in 20 
 
 
 
L SDS sample buffer and size fractionated by
SDS-PAGE. Duplicate Western blots were probed with rabbit
anti-Bim (Stressgen) or hamster anti–mouse Bcl-2 (clone 3F11)
antibodies. Bound antibodies were revealed with HRP-conju-
gated goat anti–rabbit Ig (Silenus) or goat anti–hamster Ig
(Southern Biotechnology Associates, Inc.) antibodies, respec-
tively, followed by enhanced chemiluminescence (Amersham
Biosciences).
 
Results and Discussion
 
One widely used model of B lymphocyte negative selec-
tion is stimulation in vitro with anti-IgM antibody F(ab
 
 
 
)
 
2
 
fragments (30). As previously shown (30), BCR ligation
caused apoptosis of many immature and mature B cells
from control mice within 16 h. Specific survival (calculated
by dividing the percentage of viable cells from treated cul-
tures by the percentage of viable cells from control cul-
tures; see Materials and Methods) ranged from 10 to 50%
(Fig. 1, A–C), depending on the concentration of the anti-
IgM antibodies. Anti-IgM antibodies were more potent in-
ducers of apoptosis when applied in plate-bound form (Fig.
1 C), presumably because of enhanced BCR cross-linking.
B cell death induced by BCR ligation was completely pre-
vented by expression of a 
 
bcl
 
-2 transgene and was almost
abrogated by loss of Bim (Fig. 1, A–C). The inhibition of
BCR-induced cell death in 
 
bim
 
 
 
/
 
 
 
 B cells was found to be
cell intrinsic when apoptosis of 
 
bim
 
 
 
/
 
 
 
 and 
 
bim
 
 
 
/
 
 
 
 B cells
in a mixed culture was compared with that in individual
cultures. A Ly5 allotypic difference was used to distinguish
 
bim
 
 
 
/
 
 
 
 and 
 
bim
 
 
 
/
 
 
 
 mature B cells, negatively sorted from
LNs, and cocultured for 15 h in the presence or absence of
5.0 
 
 
 
g/mL F(ab
 
 
 
)
 
2
 
 anti-IgM. This revealed 72.4 
 
 
 
 4.7%
specific survival of control B cells compared with 88.6 
 
 
 
2.0% in Bim-deficient B cells. In parallel single cultures, B
cell survival after BCR ligation was 72.4 
 
 
 
 2.1% and
89.0 
 
 
 
 0.7% for 
 
bim
 
 
 
/
 
 
 
 and 
 
bim
 
 
 
/
 
 
 
 cells, respectively.
These results demonstrate that Bim is required in immature
and mature B cells for the apoptosis induced by BCR liga-
tion in a cell intrinsic manner.
Negative selection of B cells in vivo can be studied using
Igh
 
a
 
 allotype transgenic mice producing B cells expressing
IgM and IgD BCR specific for HEL on an Igh
 
b
 
 allotype
background. In doubly transgenic animals expressing both
anti-HEL Ig and HEL as either a membrane-bound
(mHEL) or a soluble (sHEL) neo-self antigen, developing B
 
Table I.
 
Composition of Bone Marrow and Spleen in Control and mHEL
 
+
 
 Reconstituted Mice
 
Bone marrow Spleen
Donor Recipient
 
a
 
Cellularity
 
b
 
IgDa
 
+c
 
HEL binding
 
c
 
Cellularity
 
b
 
IgDa
 
+c
 
HEL binding
 
c
 
(n) 10
 
6 106 106 106 106 106
Tg+ bim+/+ Control (4) 14.9   2.5 1.2   0.3 1.1   0.4 17.8   5.6 10.8   3.5 10.4   3.5
mHEL+ (8) 10.3   2.3 0.5   0.2d 0.4   0.1e 8.1   6.1 0.3   0.2f 0.01   0.03
Tg+ bim /  Control (4) 15.5   3.0 4.0   0.6 3.6   0.5 83.5   68.3 66.1   58.7 63.6   57.3
mHEL+ (8) 11.4   3.2 1.1   0.5d 0.9   0.3e 20.6   11.9 1.7   0.9f 0.07   0.1
aRecipient mice were C57BL/6 (control) or C57BL/6 mHEL transgene positive.
bCellularity was determined by viable counts after red cell removal and are given per femur and per spleen.
cIgDa and HEL-binding cell counts are based on the proportion of cells staining positive by flow cytometry immediately ex vivo and whole organ
cell counts.
dP   0.01.
eP   0.001.
fP   0.001.T
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cells are, respectively, either deleted in the BM with few
mature B cells appearing in peripheral lymphoid organs (8),
or persist in the periphery in a functionally inactivated state
(3). Similar B lymphocyte tolerance is seen when HEL
transgenic mice are lethally irradiated and reconstituted with
hemopoietic stem cells from BM or fetal liver of anti-HEL
Ig transgenic mice (28). Indeed, we found on average 0.5  
106 transgenic IgH chain–expressing B cells per femur and
0.3   106 per spleen of mHEL transgenic animals reconsti-
tuted with control (bim / anti-HEL Ig) stem cells (Table I).
In contrast, when irradiated mHEL transgenic mice were
reconstituted with Bim-deficient anti-HEL Ig transgenic
stem cells, twofold more IgDa -expressing B cells were re-
covered from BM and sixfold more from spleen (Table I
and Fig. 2). The down-regulation of IgM on the persisting
IgDa  B cells is consistent with exposure to antigen (3).
None of the IgDa B cells from either BM or spleen bound
HEL immediately ex vivo (Fig. 2), indicating either recep-
tor editing (5) or receptor blockade by endogenous HEL.
These possibilities were resolved by sorting IgDa  B cells
from the BM and spleen of the reconstituted mHEL mice,
culturing them overnight, and then staining to test for a res-
toration of HEL binding. Sorted IgDa  B cells from BM of
both genotypes (bim /  or bim / ) recovered  85% HEL
binding after culture (Fig. 2 C). Culturing IgDa  B cells pu-
rified from the spleens of bim /  recipients, however, re-
stored HEL binding in only 15%, suggesting a permanent
alteration to the BCR specificity of the remainder (Fig. 2
C). In contrast,  60% of IgDa  B cells from bim /  spleen
recovered HEL binding. Collectively, these results show
that despite a high affinity interaction, self-reactive bim /  B
cells are produced and exist in the periphery at  25 times
the number of bim /  controls (an average of 1.0   106/
spleen compared with 0.04   106 in controls; Table II).
This is a substantial enhancement of survival of autoreactive
B cells, but the numbers of B cells are still considerably less
than those produced in mice that do not express the self-
antigen HEL. This may indicate that B cell production and
survival is also controlled by Bim-independent mechanisms.
These might include activation of other BH3-only proteins,
additional cell death mechanisms, development arrest, an-
ergy, or inhibition of cell proliferation.
The role of Bim in negative selection of mature, splenic
B cells was examined by reconstituting lethally irradiated
sHEL mice with BM from anti-HEL Ig transgenic bim / 
and bim /  mice (Fig. 3). This revealed 17-fold more self-
reactive B cells in the spleens of bim /  recipients compared
with  bim /  controls (Table III). Remarkably, an equal
number of IgH transgenic Bim-deficient B cells was found
in the spleens of self-antigen positive and negative mice,
whereas control bim /  B cells showed a 10-fold reduction
Figure 2. Bim is required for BCR stimulation–induced deletion of
self-reactive B cells in the BM. Lethally irradiated control and mHEL
transgenic mice, reconstituted with either bim /  or bim /  Ig transgenic
BM at least 8 wk previously, were analyzed for the presence of IgH
transgene  B cells. Representative FACS® profiles of BM (A) and spleen
(B) from the indicated reconstituted mice, stained with antibodies specific
for CD45R(B220) and IgDa, show the enhanced persistence of bim / 
IgDa  B cells relative to controls (see Table I for quantification and statistics).
Histograms show the level of IgM expression and HEL binding on the
B220  cells from the corresponding tissue. (C) Transgenic IgDa  cells
purified from the BM and spleens of mHEL transgenic mice reconstituted
with bim / anti-HEL Ig transgenic stem cell recover HEL binding after
overnight culture, whereas those from the spleens of bim /  anti-HEL Ig
transgenic stem cell reconstituted mice do not. IgDa  cells from BM of
both types of donor stem cells recover HEL binding (see Table II for
quantification and statistics).T
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peripheral T cell tolerance to be normal despite significant
abnormalities in the thymus of bim /  mice (24).
The failure to delete Bim-deficient B cells in the pres-
ence of their cognate self-antigen could result from changes
to any of several mechanisms associated with the imposi-
tion and maintenance of B cell tolerance (33). To investi-
gate further the basis of the bim /  B cell persistence, a
mixture of mature, peripheral B cells from bim /  and
bim /  Ig transgenic mice marked by a Ly5 allotypic differ-
ence was transferred into recipients that either expressed
sHEL or did not. 2 and 5 d later, groups of such recipients
were killed, and the representation of Ig transgenic B cells
remaining was determined. The bim /  and bim /  B cells
were resolved by their Ly5 allotypes in the recipients. In
control recipients, both types of B cells remained detectable
during the time course of the assay despite diminishing in
representation (Fig. 3). The rate of loss of bim /  B cells
appeared to be less than that of bim /  B cells—not an un-
expected result given the enhanced survival of bim /  B
cells under conditions of limiting availability of growth fac-
tors (23). In sHEL  recipients, control Ig transgenic B cells
were detectable at day 2 posttransfer but not by day 5 (Fig.
3 B), indicating an accelerated turnover (death) in the pres-
in absolute number or a threefold reduction in proportion
in the presence of self-antigen (Table III); both changes
were within the range reported for this model of B cell tol-
erance (31). The larger reduction in B cell number com-
pared with proportion reflects the reduced cellularity of the
spleens of sHEL  mice reconstituted with bim /  BM
rather than the loss of only B lymphocytes (Table III), again
a previously reported property of this system (31). Irrespec-
tive of their bim genotype, the persistent IgDa  B cells in
the sHEL  recipients retained the ability to bind HEL and
expressed unaltered levels of IgDa, showed down-regula-
tion of IgM, and did not acquire high levels of CD21 (Fig.
3), all indicative of chronic exposure to antigen (3, 32). In
addition, the titers of anti-HEL antibody in sHEL  recipi-
ents of both genotypes were the same (unpublished data).
Thus, the persistence of these IgDa  bim /  B cells was not
due to either enhanced receptor editing or masking of the
self epitope by excessive secretion of specific antibody. Fur-
thermore, these results indicated that although autoreactive
Bim-deficient B cells were refractory to apoptosis, systemic
tolerance was maintained. This presumably reflects in part
the maintenance of T cell tolerance to HEL in the bim / 
mice, a result consistent with our previous studies showing
Table III. Persistence of Bim-deficient HEL-binding B Cells in the Presence of Soluble Self-antigen
Donora Recipientb Cellularityc IgDa+ IgDa+d HEL bindingd
(n) 106 % of organ 106 106
Tg+ bim+/+ Control (3) 29.3   9.5 55.9   2.3 16.4   5.6 15.0   4.7
sHEL+ (3) 8.1   3.1 17.3   7.5 1.4   0.9e 1.2   0.9f
Tg+ bim /  Control (3) 51.5   17.3 51.8   12.3 26.7   14.6 23.3   14.7
sHEL+ (3) 86.7   54.3 29.3   11.4 25.4   13.8e 20.2   13.9f
aGenotype of bone marrow donor used in original reconstitution.
bRecipients were either C57Bl/6 (control) or C57Bl/6 sHEL transgene positive.
cCellularity is as defined in Table I.
dIgDa and HEL-binding counts are as determined for Table I.
eP   0.05.
fP   0.07.
Table II. Restoration of HEL Binding after Culture of Bim-deficient Splenic B Cells Sorted from mHEL+ Mice
Tissue
mHEL+ recipient 
reconstituted with: IgDa+ cells/organ
Restored  HEL binding 
after culturea HEL reactive cellsb 
106 %1 0 6
Bone marrow Tg+ bim+/+ 0.5   0.2 86.5   4.9 0.43
Tg+ bim /  1.1   0.5 95.3   3.1 1.05
Spleen Tg+ bim+/+ 0.3   0.2 14.0   2.8 0.04
Tg+ bim /  1.7   0.9 58.7   6.0 1.00
aHEL binding is measured by flow cytometric staining  after overnight culture, shown in Fig. 2 C.
bCalculates number of cells retaining HEL specificity as revealed after cell culture.T
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ence of their cognate antigen, a result consistent with pre-
vious reports (34, 35). Bim-deficient B cells, on the other
hand, remained detectable during this period and, if any-
thing, appeared to increase in representation (Fig. 3 B).
Thus, mature bim /  B cells persist in the periphery in the
presence of antigen due to extended survival.
In view of the critical role of Bim in triggering deletion
of autoreactive B lymphocytes, we investigated how BCR
ligation affected its association with other components of
the cell death pathway. In healthy cells, most BimL and
BimEL molecules are sequestered to the microtubular dy-
nein motor complex by binding to the dynein light chain
DLC1/LC8 (29). Certain apoptotic stimuli release Bim
from this complex, allowing it to translocate and bind to
Bcl-2 or its homologues, thereby blocking their survival
function (29). Therefore, we investigated whether BCR li-
gation triggered translocation of Bim to Bcl-2, the domi-
nant prosurvival Bcl-2 family member expressed in B lym-
phocytes. Lysates were prepared from B cells that had been
stimulated for 16 h with anti-IgM antibodies or left un-
treated, and Bcl-2 immunoprecipitates subjected to West-
ern blot analysis with anti-Bim antibodies. The levels of
BimL and BimEL complexed with Bcl-2 increased substan-
tially upon BCR stimulation, whereas the total amount of
Bim increased (approximately twofold) and Bcl-2 levels
dropped (approximately twofold) (Fig. 4, A and B). Thus,
increased association of Bim with Bcl-2 in activated B cells
supports its role in BCR-mediated apoptosis.
Figure 3. Bim is required for BCR stimulation–induced deletion of
mature B cells in the absence of T cell help. (A) Lethally irradiated control
and sHEL-expressing mice, reconstituted with either bim /  or bim / 
anti-HEL Ig transgenic BM previously at least 8 wk, were analyzed for
the persistence of transgenic IgH B cells in the spleen. Shown are contour
plots of the expression of B220 and IgDa and histograms depicting ex-
pression of IgM, HEL binding, and CD21 on those cells within the gated
regions defining B220  cells. Quantification of the B cell populations in
the spleens of these mice is given in Table III. (B) Mature bim /  ( ) and
bim /  ( ) B cells were transferred into sHEL  (top) and sHEL  (bottom)
recipients, and their representations were determined 2 and 5 d later. The
proportion of each B cell type in recipient’s spleens, as assessed by flow
cytometry following staining for IgDa, Ly5.2, and HEL binding, is plotted.
At each time point, two sHEL  and three sHEL  recipients were examined,
and the solid bar is the average of the mice of that genotype.
Figure 4. BCR ligation promotes binding of Bim to Bcl-2. (A) Coimmu-
noprecipitation of Bim with Bcl-2. After lysis proteins were immuno-
precipitated with Bcl-2 antibody, the immunoprecipitated proteins were
fractionated by SDS-PAGE, blotted onto membranes, and probed with
antibodies to BimL and BimEL (top) or Bcl-2 (bottom). (B) Western blot
analysis of extracts from B cells that had been stimulated in culture with
cross-linking F(ab )2 anti-IgM antibodies or left untreated, using antibodies
to Bim and Bcl-2.T
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The biochemical data presented in this report showing
that Bim mediates BCR-induced apoptosis by sequestering
Bcl-2 suggests an important role for Bcl-2 itself in B cell
tolerance. Perhaps not surprisingly this was found to be the
case in several diverse situations. First, constitutive, B cell–
restricted expression of a human bcl-2 transgene abrogated
the normal mechanisms of B cell tolerance in that these
mice developed an eventually lethal antibody-mediated au-
toimmune condition reminiscent of human system lupus
erythematosus (33). Second, crossing these bcl-2 transgene
onto the HEL/anti-HEL Ig self-antigen/antiself antibody
system used in this study produced a phenotype similar to
that reported here for the Bim-deficient mice. Hartley and
colleagues found that Bcl-2 overexpression increased the
number of Ig transgenic B cells in the periphery of mHEL 
mice by approximately fivefold (10), just as we find a five-
fold increase in IgDa transgenic bim /  B cells in the
spleens of mHEL  recipients (Table I). This indicates that
the majority of the effects seen in the bcl-2 transgenic mice
are directly due to its inhibition of Bim’s pro-apoptotic ac-
tivity and that consequently Bim is a major mediator of tol-
erance induction in B cells.
Collectively, these studies from four models of negative
selection indicate that activation of Bim is a primary trig-
ger for killing autoreactive B cells during their develop-
ment in the BM and at the mature stage in the spleen. It is
noteworthy that Bim deficiency inhibits BCR ligation–
induced apoptosis of cultured B cells less potently than
overexpression of Bcl-2 (Fig. 1), indicating that BH3-only
proteins in addition to Bim may also be involved in this
death pathway. Blk is a possible candidate because its ex-
pression was found to increase upon BCR ligation in a
human B lymphoma–derived cell line (34). Although the
detailed mechanisms of Bim activation remain unclear,
our results identify Bim as an essential initiator of apopto-
sis in autoreactive B cells. Bim is also critical for negative
selection of autoreactive thymocytes (24) and for deletion
of antigen-activated mature T cells (25, 26). Thus, Bim
appears essential for apoptosis induction of B and T lym-
phocytes in both central and peripheral tolerance. The re-
tention of autoreactive lymphocytes in Bim-deficient ani-
mals is presumably the basis of the SLE-like autoimmune
disease they develop (23) and suggests that diminished
Bim activity may underlie some forms of human autoim-
mune disease.
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